ClinicalTrials.Veeva

Menu

Abdominal Wall Transplant

Duke University logo

Duke University

Status

Enrolling

Conditions

Transplant; Failure, Liver
Transplant; Failure, Bowel
Abdominal Wall Hernia
Abdominal Wall Defect
Abdominal Wall Fistula
Transplant;Failure,Kidney
Abdominal Wall Injury

Treatments

Procedure: Abdominal Wall Transplant with another solid organ transplant
Procedure: Abdominal Wall Transplant alone

Study type

Interventional

Funder types

Other

Identifiers

NCT03310905
Pro00084054

Details and patient eligibility

About

The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.

Full description

Within this protocol we propose to perform abdominal wall transplantation in 5 subjects, either as an isolated abdominal wall or in combination with another organ transplant. Each subject will be followed for a study period of 18 months.

Participants receiving an isolated abdominal wall or abdominal wall in combination with another organ transplant will receive the standard immunosuppression therapy as the non-vascularized composite allograft organ transplant. These patients will be studied to determine efficacy of the abdominal wall transplant to restore function of the defective abdominal wall for a study period of 18 months at Duke University Medical Center.

Enrollment

5 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Candidates between 18-65 years old
  • Willingness and legal ability to give consent
  • Abdominal Wall in combination with another organ transplant: they must be eligible for the non-vascularized composite allograft organ transplant at Duke

Exclusion criteria

  • Malignancy at evaluation or history of malignancy that precludes transplantation
  • Pregnancy: Women who are of childbearing potential must have a negative serum pregnancy test within 48 hours of transplant and agree to use reliable contraception with two contraceptive methods for a minimum of 2 years following abdominal wall transplantation. Subjects seeking to become pregnant following 2 years will be made aware during the consent process that the effect of pregnancy on the transplanted abdominal wall and vice versa is unknown.
  • Medical exclusion criteria for general anesthesia
  • Ongoing substance abuse or history of untreated substance abuse

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

5 participants in 2 patient groups

Isolated Abdominal Wall Transplant
Experimental group
Treatment:
Procedure: Abdominal Wall Transplant alone
Abdominal Wall with Solid Organ Transplant
Experimental group
Treatment:
Procedure: Abdominal Wall Transplant with another solid organ transplant

Trial contacts and locations

1

Loading...

Central trial contact

Linda Cendales, MD; Kadiyala Ravindra, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems